Hutch News

Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel

Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel

The newly-approved CAR T-cell therapy was developed in part by Fred Hutch physician-scientists
News Releases - February 05, 2021
Mariners honor cancer survivor Colin Craig

Mariners honor cancer survivor Colin Craig

Seattle native works to support lifesaving research — like the immunotherapy that put his cancer in remission
Hutch News - May 03, 2018
Fred Hutch opens first-of-its kind Bezos Family Immunotherapy Clinic

Fred Hutch opens first-of-its kind Bezos Family Immunotherapy Clinic

Clinic will allow researchers to conduct twice as many immunotherapy trials, enable intensive patient monitoring to improve experimental therapies
Hutch News - November 01, 2016
Dramatic remissions seen in immunotherapy trial of blood cancer patients

Dramatic remissions seen in immunotherapy trial of blood cancer patients

Experimental, living T-cell therapy shows promise for treating advanced disease, making immunotherapy a ‘pillar’ of cancer care
Hutch News - February 16, 2016
Many immunotherapy trial participants with blood cancer in remission, preliminary results show

Many immunotherapy trial participants with blood cancer in remission, preliminary results show

High rates of complete remission reported in patients with advanced blood cancers in preliminary results from ongoing immunotherapy trial
Hutch News - December 07, 2015
A lifetime later, a bone marrow donor and recipient return to Fred Hutch

A lifetime later, a bone marrow donor and recipient return to Fred Hutch

25 years ago, Jennifer Monteleone donated her marrow to her 6-year-old brother, Michael
Hutch News - July 16, 2015